RVO
HomeMarketplace
Register
Register
Register

PartnershipUpdated on 12 August 2025

Biomedical Production Technology (NXTGEN Hightech)

Ingrid Relou

Program Manager at NXTGEN Hightech

Eindhoven, Netherlands

About

Biomedical Production Technology, one of NXTGEN Hightech’s six focus areas, connects cutting-edge science and industry to deliver faster, safer, and more personalized medical technologies. We translate advances in Lab-on-Chip, Organ-on-Chip, Artificial Organs, and Cell Production Technology into scalable, market-ready systems.

Our network of 60+ public and private partners spans high-tech, microtechnology, biology, clinical practice, and regulatory sectors. Together, we bridge the gap between fundamental research and industrial-scale manufacturing, emphasizing regulatory alignment and system standardization to speed up clinical adoption.

We are developing a joint platform that accelerates biomedical technology by offering shared production infrastructure, generic equipment, standardized and qualified processes, and facilities — all accessible via one central virtual hub.

We welcome collaborations with developers, suppliers, researchers, and end-users seeking to innovate in biomedical technology production.

Organisation

NXTGEN Hightech

Other

Eindhoven, Netherlands

Similar opportunities

  • Service

    Platform development services

    • Consulting
    • Development
    • Manufacturing
    • Innovative therapies - Microbiome therapy
    • High Tech Systems & Materials - Chip design
    • Innovative human-based test models - 3D spheroids
    • Innovative human-based test models - Organ-on-Chip
    • Development stages and support fuctions - Contract research (CRO / CRMO)
    • Innovative human-based test models - 2D & 3D in vitro cell culture models
    • Development stages and support fuctions - Early discovery / basic research
    • Development stages and support fuctions - Technology development and validation
    • Development stages and support fuctions - Pre-clinical research and development

    Sanne de Wit

    Operations and Programme Manager at University of Twente at University of Twente

    Enschede, Netherlands

  • Service

    Medical Devices & IVDs & Combination Products Services

    • Others
    • Consulting
    • Development stages and support fuctions - Regulatory and compliance
    • Development stages and support fuctions - Technology development and validation

    Jane Müller

    Head Legal, Business Development representative at Luminance Health

    Basel, Switzerland

  • Service

    CMC Consulting

    • Consulting
    • Development
    • Innovative therapies - Gene therapy
    • Innovative therapies - Stem cell therapy
    • Innovative therapies - Oncolytic viruses
    • Innovative therapies - Immune cell therapy
    • Innovative therapies - Somatic cell therapy
    • Development stages and support fuctions - Data management and analytics
    • Development stages and support fuctions - Contract research (CRO / CRMO)
    • Development stages and support fuctions - Clinical research and development
    • Development stages and support fuctions - Development and (GMP) manufacturing
    • Development stages and support fuctions - Pre-clinical research and development
    • Development stages and support fuctions - Commercial strategy and market access

    daniel lüscher

    CEO at QBDC GmbH

    Nusshof, Switzerland